Science37

Science37 (operating at science37.com) is a clinical research platform engineered for decentralized clinical trials. Founded in 2014 by Belinda Tan and Noah Craft and headquartered in Morrisville, North Carolina, Science37 revolutionizes patient recruitment by eliminating traditional barriers to trial participation. Under the hood, the company leverages a Direct-to-Patient (DTP) model, combining nationwide medical licensure across all 50 states with a mobile-first approach to connect patients directly to studies from their homes. This allows sponsors and researchers to expand trial reach, reduce geographic constraints, and accelerate enrollment while improving patient accessibility. Backed by $106 million in funding from investors like Lux Capital, Redmile Group, and Glynn Capital, Science37 has positioned itself as an industry leader in virtual and hybrid clinical trials.